6654 MRS20Logo 8

The rising frequency of chronic illnesses such as central nervous system disorders and cardiovascular disease is the primary driver of the transdermal medication delivery systems market. According to Heart Disease Facts 2020, around 18.2 million persons aged 20 and up have coronary heart disease (about 6.7 percent). As chronic disorders such as cardiovascular disease become more prevalent, there will be an increase in demand for transdermal medication delivery systems, hence boosting the industry for transdermal drug delivery devices.

North America is predicted to account for the highest proportion of the transdermal drug delivery devices market among all regions. This can be attributed to the rising incidence of chronic pain, cardiovascular disorders, and central nervous system disorders in the region, as well as the increased use of contraceptives and research activities related of transdermal drug carriers, which are expected to be the major influential factors in driving the market’s total growth over the coming years.

Request a Free Sample Copy: https://marketresearchstrategy.com/request-sample-report/1114 

List of Key Players- Transdermal Drug Delivery Devices Market

  • Mylan
  • Hisamitsu Pharmaceutical
  • Novartis, UCB SA
  • Boehringer Ingelheim
  • GlaxoSmithKline
  • Endo International
  • Johnson & Johnson
  • Bristol-Myers Squibb Company
  • Purdue Pharma
  • Acrux Limited
  • Endo Pharmaceuticals Inc.
  • Luye Pharma Group
  • Lavipharm, Lead Chemicals Co. Inc.
  • F. Hoffmann-La Roche Ltd.

According to Alzheimer’s Disease International 2020, there is more than 50 million persons globally suffering from dementia in 2020. It is anticipated that the population would double every 20 years, hitting 82 million in 2030 and 152 million in 2050. Because of a surge in chronic illnesses such as brain diseases, demand for transdermal drug delivery devices will rise, boosting the industry for transdermal drug delivery devices.

Transdermal Drug Delivery Devices Market Report Highlights

  • Hisamitsu Pharmaceutical Co., Inc. announced on December 07, 2020, that transdermal, pain treatment NSAID patch had accomplished the primary outcome of the LP03 study, Phase III clinical clinical study for “back pain,” and the LP04 study, Phase III clinical study for “humeroscapular likely to be multifactorial, cervico-omo-brachial syndrome, and tenosynovitis” in Japan.
  • Hisamitsu Pharmaceutical Co., Inc., in July 21, 2020 announced that it had received manufacturing and sales authorisation for OABLOK PATCH in Thailand.

TRANSDERMAL DRUG DELIVERY DEVICES MARKET SEGMENTATION

The research report published by Market Research Strategy contains industry segments, as below-

Transdermal Drug Delivery Devices Market Type Outlook (Revenue, USD Million, 2016 – 2027)

  • Drug-In-Adhesive Patches
  • Matrix Patches
  • Microneedle Patches
  • Reservoir Membrane Patches

Transdermal Drug Delivery Devices Market Application Type Outlook (Revenue, USD Million, 2016 – 2027)

  • Cardiovascular Diseases
  • Central Nervous System Disorders
  • Hormonal Applications
  • Pain Management
  • Others

Transdermal Drug Delivery Devices Market End-Use Outlook (Revenue, USD Million, 2016 – 2027)

  • Hospitals
  • Ambulatory Surgical Centers
  • Others 

Transdermal Drug Delivery Devices Market Regional Outlook (Revenue, USD Million, 2016 – 2027)

  • North America (U.S., and Canada)
  • Europe (Germany, U.K., France, Italy, Spain etc.)
  • Asia-Pacific (China, India, Japan, Indonesia, Malaysia, Australia, South Korea, etc.)
  • South America (Brazil, Mexico, Argentina etc.)
  • Middle East & Africa (Saudi Arabia, Kuwait, UAE, South Africa etc.)

To know more about the report @ https://marketresearchstrategy.com/reports/healthcare/transdermal-drug-delivery-devices-market 

Browse Our Related Reports: 

Life Science Products Market Status (2016-2020) and Forecast Market Analysis, Regional Outlook, Segment Growth Potential, and Competitive Market Share Analysis, 2021-2027

Healthcare Interoperability Solutions Market Status (2016-2020) and Forecast Market Analysis, Regional Outlook, Segment Growth Potential, and Competitive Market Share Analysis, 2021-2027

Transient Elastography Devices Market Status (2016-2020) and Forecast Market Analysis, Regional Outlook, Segment Growth Potential, and Competitive Market Share Analysis, 2021-2027

About Market Research Strategy:

Market Research Strategy (MRS) is a dedicated and disciplined market research firm that delivers authentic consulting services with accurate data forecasting for research-related services. The positive and result-oriented approaches implemented by us are beneficial in identifying the market challenges of any brand or start-up company to penetrate the competitive business space.

MRS also supports numerous organizations with its syndicate data and research reports to establish and survive in the market by grabbing the available market opportunities. Our vast experience and huge client database turn out to be our wealth and also secures our market position at the top of the list. Besides, we make use of every single piece of information, mined from authentic sources, into a valuable asset of the report; aiding our clients with informed business decisions. 

Tags: Transdermal Drug Delivery Devices Market Trends, Transdermal Drug Delivery Devices Market, Transdermal Drug Delivery Devices Market Size, Transdermal Drug Delivery Devices Market Share, Transdermal Drug Delivery Devices Market Growth

See Campaign: https://marketresearchstrategy.com/reports/healthcare/transdermal-drug-delivery-devices-market

Contact Information:

Market Research Strategy USA Phone: +1 9176726599 Business Email: sales@marketresearchstrategy.com Website: https://marketresearchstrategy.com/

Tags:
PR-Wirein, Reportedtimes, iCN Internal Distribution, Research Newswire, English